Patient no. | Gender | Cause of the primary vitrectomy | Concurrent procedure | Using a tamponading agent in the primary PPvitx | Treatment method |
---|---|---|---|---|---|
1 | Male | Diabetic retinopathy | Intravitreal bevacizumab | – | Rescue vitrectomy + intravitreal antibiotics |
2 | Female | Diabetic retinopathy | Intravitreal bevacizumab | – | Intravitreal antibiotics |
3 | Female | Diabetic retinopathy | Intravitreal bevacizumab | SF6 20% | Intravitreal antibiotics |
4 | Male | Rhegmatogenous retinal detachment | – | Silicon oil | Rescue vitrectomy + intravitreal antibiotics |
5 | Male | Rhegmatogenous retinal detachment | – | Silicon oil | Rescue vitrectomy + intravitreal antibiotics |
6 | Female | Epiretinal membrane | Cataract surgery | – | Rescue vitrectomy + intravitreal antibiotics |
7 | Female | Diabetic retinopathy | Intravitreal bevacizumab | – | Intravitreal antibiotics |
8 | Female | Non-clearing vitreous hemorrhage secondary to CRVO | – | – | Rescue vitrectomy + intravitreal antibiotics |
9 | Female | Diabetic retinopathy | Intravitreal bevacizumab | Silicon oil | Intravitreal antibiotics |
10 | Male | Diabetic retinopathy | Intravitreal bevacizumab | – | Intravitreal antibiotics |
11 | Female | Diabetic retinopathy | Intravitreal bevacizumab | SF6 20% | Rescue vitrectomy + intravitreal antibiotics |
12 | Female | Diabetic retinopathy | – | – | Intravitreal antibiotics |